ADIPOQ and renal cell carcinoma: Higher levels of adiponectin with metformin therapy may therefore suggest a mechanism for improved outcomes in RCC [149] but possibly not in glomerulonephritis, where adiponectin levels are elevated in the absence of metformin [142].